Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Colorectal Cancer
Pharma company engages WorldCare Clinical diagnostics services
March 31st, 2005
Pro-Pharmaceuticals, Inc., (PRW) announced that it has engaged WorldCare Clinical to deliver state of the art diagnostic services for its phase II trial, including acquisition, interpretation, and digital analysis of patients images. Also, Steven Nagel, MD, FACS, of PRA International, was named Medical Monitor for the phase ll colorectal cancer trial. WorldCare will support PRA International, which is managing and monitoring the trial, and Medidata Solutions, which is providing electronic data capture and trend analysis. "PRA International, a leading clinical development organization, has long recognized the value added to...
Source: Women's Health Weekly (2005-03-31)
|
